The best treatment for a patient battling cancer

sometimes includes an exclusive medication not yet available because of the lengthy time it takes new treatments to reach oncologists after the final stages of development. Through Michiana Hematology Oncology's direct involvement with the Northern Indiana Cancer Research Consortium (NICRC), many of these breakthrough medications are already available to patients in our region. In fact, just to be sure every possible treatment option is considered, the specialists at Michiana Hematology Oncology assess each patient’s potential for success with the latest and most exclusive cancer treatments currently being developed around the world.